Compliance with pregnancy prevention measures during isotretinoin therapy

Mary Katharine Collins, Jacqueline F. Moreau, Dan Opel, James Swan, Noel Prevost, Matthew Hastings, Eleanor Schwarz, Laura Korb Ferris

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background Approximately 150 women annually become pregnant while taking isotretinoin despite participation in the iPLEDGE program. Noncompliance with the requirement to be abstinent or use 2 contraceptive methods may be a contributing factor. Objective We sought to determine the degree of adherence to contraception or abstinence among women taking isotretinoin. Methods We conducted an anonymous survey of women of childbearing potential taking isotretinoin for at least 2 months. Results Among 75 participants, 21 (28%) chose abstinence as their primary means of pregnancy prevention, of whom 4 (19%) were sexually active during treatment. The most commonly chosen contraceptive methods among the 39 women who were sexually active were condoms (35, 90%) and oral contraceptive pills (18, 46%). Twelve women (31%) admitted to having intercourse at least once using 1 or fewer forms of contraception; 10 failed to use condoms, and 1 reported completely unprotected intercourse. Among sexually active oral contraceptive pill users, 7 (39%) reported missing 1 or more pills in the previous month. Limitations Data were self-reported, thus participants may have inaccurately reported contraception use. Conclusions Encouraging the use of highly effective, patient-independent contraception and limiting abstinence to women who have never been sexually active may further reduce the rate of isotretinoin-exposed pregnancies.

Original languageEnglish (US)
Pages (from-to)55-59
Number of pages5
JournalJournal of the American Academy of Dermatology
Volume70
Issue number1
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Isotretinoin
Contraception
Pregnancy
Condoms
Oral Contraceptives
Therapeutics

Keywords

  • acne
  • condoms
  • contraception
  • intrauterine device
  • iPLEDGE
  • isotretinoin
  • oral contraceptive pills

ASJC Scopus subject areas

  • Dermatology

Cite this

Collins, M. K., Moreau, J. F., Opel, D., Swan, J., Prevost, N., Hastings, M., ... Korb Ferris, L. (2014). Compliance with pregnancy prevention measures during isotretinoin therapy. Journal of the American Academy of Dermatology, 70(1), 55-59. https://doi.org/10.1016/j.jaad.2013.08.034

Compliance with pregnancy prevention measures during isotretinoin therapy. / Collins, Mary Katharine; Moreau, Jacqueline F.; Opel, Dan; Swan, James; Prevost, Noel; Hastings, Matthew; Schwarz, Eleanor; Korb Ferris, Laura.

In: Journal of the American Academy of Dermatology, Vol. 70, No. 1, 01.01.2014, p. 55-59.

Research output: Contribution to journalArticle

Collins, MK, Moreau, JF, Opel, D, Swan, J, Prevost, N, Hastings, M, Schwarz, E & Korb Ferris, L 2014, 'Compliance with pregnancy prevention measures during isotretinoin therapy', Journal of the American Academy of Dermatology, vol. 70, no. 1, pp. 55-59. https://doi.org/10.1016/j.jaad.2013.08.034
Collins, Mary Katharine ; Moreau, Jacqueline F. ; Opel, Dan ; Swan, James ; Prevost, Noel ; Hastings, Matthew ; Schwarz, Eleanor ; Korb Ferris, Laura. / Compliance with pregnancy prevention measures during isotretinoin therapy. In: Journal of the American Academy of Dermatology. 2014 ; Vol. 70, No. 1. pp. 55-59.
@article{17c0136f3bd34f13986516453423ec55,
title = "Compliance with pregnancy prevention measures during isotretinoin therapy",
abstract = "Background Approximately 150 women annually become pregnant while taking isotretinoin despite participation in the iPLEDGE program. Noncompliance with the requirement to be abstinent or use 2 contraceptive methods may be a contributing factor. Objective We sought to determine the degree of adherence to contraception or abstinence among women taking isotretinoin. Methods We conducted an anonymous survey of women of childbearing potential taking isotretinoin for at least 2 months. Results Among 75 participants, 21 (28{\%}) chose abstinence as their primary means of pregnancy prevention, of whom 4 (19{\%}) were sexually active during treatment. The most commonly chosen contraceptive methods among the 39 women who were sexually active were condoms (35, 90{\%}) and oral contraceptive pills (18, 46{\%}). Twelve women (31{\%}) admitted to having intercourse at least once using 1 or fewer forms of contraception; 10 failed to use condoms, and 1 reported completely unprotected intercourse. Among sexually active oral contraceptive pill users, 7 (39{\%}) reported missing 1 or more pills in the previous month. Limitations Data were self-reported, thus participants may have inaccurately reported contraception use. Conclusions Encouraging the use of highly effective, patient-independent contraception and limiting abstinence to women who have never been sexually active may further reduce the rate of isotretinoin-exposed pregnancies.",
keywords = "acne, condoms, contraception, intrauterine device, iPLEDGE, isotretinoin, oral contraceptive pills",
author = "Collins, {Mary Katharine} and Moreau, {Jacqueline F.} and Dan Opel and James Swan and Noel Prevost and Matthew Hastings and Eleanor Schwarz and {Korb Ferris}, Laura",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.jaad.2013.08.034",
language = "English (US)",
volume = "70",
pages = "55--59",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Compliance with pregnancy prevention measures during isotretinoin therapy

AU - Collins, Mary Katharine

AU - Moreau, Jacqueline F.

AU - Opel, Dan

AU - Swan, James

AU - Prevost, Noel

AU - Hastings, Matthew

AU - Schwarz, Eleanor

AU - Korb Ferris, Laura

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background Approximately 150 women annually become pregnant while taking isotretinoin despite participation in the iPLEDGE program. Noncompliance with the requirement to be abstinent or use 2 contraceptive methods may be a contributing factor. Objective We sought to determine the degree of adherence to contraception or abstinence among women taking isotretinoin. Methods We conducted an anonymous survey of women of childbearing potential taking isotretinoin for at least 2 months. Results Among 75 participants, 21 (28%) chose abstinence as their primary means of pregnancy prevention, of whom 4 (19%) were sexually active during treatment. The most commonly chosen contraceptive methods among the 39 women who were sexually active were condoms (35, 90%) and oral contraceptive pills (18, 46%). Twelve women (31%) admitted to having intercourse at least once using 1 or fewer forms of contraception; 10 failed to use condoms, and 1 reported completely unprotected intercourse. Among sexually active oral contraceptive pill users, 7 (39%) reported missing 1 or more pills in the previous month. Limitations Data were self-reported, thus participants may have inaccurately reported contraception use. Conclusions Encouraging the use of highly effective, patient-independent contraception and limiting abstinence to women who have never been sexually active may further reduce the rate of isotretinoin-exposed pregnancies.

AB - Background Approximately 150 women annually become pregnant while taking isotretinoin despite participation in the iPLEDGE program. Noncompliance with the requirement to be abstinent or use 2 contraceptive methods may be a contributing factor. Objective We sought to determine the degree of adherence to contraception or abstinence among women taking isotretinoin. Methods We conducted an anonymous survey of women of childbearing potential taking isotretinoin for at least 2 months. Results Among 75 participants, 21 (28%) chose abstinence as their primary means of pregnancy prevention, of whom 4 (19%) were sexually active during treatment. The most commonly chosen contraceptive methods among the 39 women who were sexually active were condoms (35, 90%) and oral contraceptive pills (18, 46%). Twelve women (31%) admitted to having intercourse at least once using 1 or fewer forms of contraception; 10 failed to use condoms, and 1 reported completely unprotected intercourse. Among sexually active oral contraceptive pill users, 7 (39%) reported missing 1 or more pills in the previous month. Limitations Data were self-reported, thus participants may have inaccurately reported contraception use. Conclusions Encouraging the use of highly effective, patient-independent contraception and limiting abstinence to women who have never been sexually active may further reduce the rate of isotretinoin-exposed pregnancies.

KW - acne

KW - condoms

KW - contraception

KW - intrauterine device

KW - iPLEDGE

KW - isotretinoin

KW - oral contraceptive pills

UR - http://www.scopus.com/inward/record.url?scp=84890799385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890799385&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2013.08.034

DO - 10.1016/j.jaad.2013.08.034

M3 - Article

VL - 70

SP - 55

EP - 59

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 1

ER -